Market Closed - Euronext Paris 16:35:13 18/06/2024 BST After market 17:47:31
2.16 EUR -4.00% Intraday chart for CARMAT 2.195 +1.62%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Carmat: under pressure after equitization operation CF
CARMAT : Invest Securities remains Buy, lowers its target CF
Oddo BHF Cuts Carmat PT, Affirms Neutral Rating MT
CARMAT : price target lowered by Oddo BHF CF
Carmat Raises EUR16 Million for Ongoing Operations, Clinical Trial MT
Carmat: 16 million euros successfully raised CF
Carmat: launches a fund-raising campaign of around €15 million CF
Carmat "optimistic" about its artificial heart clinical trial, share price rises RE
Carmat: progress in ongoing clinical study CF
CARMAT Continues to Build on Its Momentum in the EFICAS Study CI
Carmat SA Reiterates Sales Guidance for the Year 2024 CI
Carmat SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
MARKET UPDATE-Consolidation in equities ahead of inflation figures RE
Europe stable as we await further inflation data RE
Carmat: final agreement with creditors CF
Carmat Secures Two-year Extensions for Bank Loans MT
CARMAT Announces a Final Agreement with All Its Financial Creditors on New Repayment Terms for Its Bank Loans CI
Carmat: up sharply, broker upgrades to 'buy CF
CARMAT : Invest Securities upgrades to 'buy'. CF
Oddo BHF Keeps Carmat at Neutral, Cuts PT MT
France’s Carmat Secures EUR17 Million via Capital Raise; Shares Fall MT
CARMAT : price target lowered by Oddo BHF CF
Carmat: capital increase completed CF
Carmat SA announced that it has received ?16.5186 million in funding CI
CARMAT : Invest Securities advises to subscribe CF
Chart CARMAT
More charts
CARMAT specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnostics system. The artificial heart is intended for patients with advanced cardiac insufficiency who are ineligible for a transplant and have exhausted all medication alternatives.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.25 EUR
Average target price
12.32 EUR
Spread / Average Target
+447.78%
Consensus
  1. Stock Market
  2. Equities
  3. ALCAR Stock
  4. News CARMAT
  5. Oddo BHF Cuts Carmat PT, Affirms Neutral Rating
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW